Jazz2025JPMPresentation_FINAL

January 2025Innovating to Transform the Lives of Patients and Their Families43rd Annual J.P. Morgan Healthcare ConferenceJanuary 2025MarkellaEPIDIOLEX® patient diagnosed with Dravet syndromeJanuary 2025Transforming Lives. Redefining Possibilities.2Caution Concerning Forward-Looking StatementsThis presentation contains forward-looking statements and financial targets, including, but not limited to, statements related to: the Company’s growth prospects and future financial and operating results, including the ability of the Company’s portfolio to drive long-term shareholder value; expectations with respect to indication expansion opportunities; 2024 total, neuroscience and oncology revenue guidance and the Company’s expectations related thereto; the Company’s ability to drive significant cash flow generation; the Company’s commercial expectations, including with respect to revenue diversification and its expectations for significant growth; the Company’s expectations with respect to the